The Jawaharlal Nehru Medical College Hospital, Aligarh Muslim University is planning to open “Out-Patient Department (OPD)” in a phased manner. The Principal JNMCH Professor Shahid Ali Siddiqui will consult the university authorities and chairpersons and decision may be taken in the next few days depending upon the COVID-19 situation, staff position and availability of resources. Till now the various OPDs were working through on-line mode (Telemedicine).
The Principal informed that OPD’s will open with proper mandatory precautions such as Social Distancing, Hygiene, Sanitation, wearing of masks etc.
Opening of OPD’s will also help in enrolment of subjects for the Covid-19 trial.
Prof Mohd Shameem, Principal Investigator for Covaxin phase 3 trial informed that the registration is moving satisfactory but there is an exclusion as well as inclusion criteria and other detailed procedural/protocol formalities for the COVAXIN trial. He informed that written consent and other related formalities will be completed in due course of time.
Prof Mohd Shameem, Principal Investigator, further informed that the Vice-Chancellor had volunteered himself for Phase-3 trial of COVID-19 vaccine “Covaxin”. According to the protocol for the trial, “person participating in the trial should not have taken any licensed/experimental vaccine within 4 weeks before enrolment in the study”. On perusal of his recent medical history by the Principal Investigator, it has come to light that a few days back, the Vice-Chancellor was administered influenza vaccine (Fluarex-Tetra), which is administered to him annually. Since his case falls in the exclusionary criteria according to the protocol for the vaccine trial, he may not be able to participate in the trials, and hence his name will not be included in the initial study period of the trial.
So far, more than 250 applications have been received for the trial. All applications will be screened as per the protocol and procedure laid down by ICMR before inclusion in the study/trial. The resource persons from Bharat Biotech will visit AMU in the coming days for training of staff for the vaccine trials.